Gilead Sciences
Liver Diseases
Gilead R&D has helped transform the treatment of chronic hepatitis C infection and help manage chronic hepatitis B infection. The company’s liver disease research focuses on medicines for nonalcoholic steatohepatitis (NASH) in patients with advanced fibrosis and on the long-term suppression of hepatitis B virus.